Form Type: 4

SEC EDGAR Link
Accession Number:0001140361-21-033351
Date:2021-10-01
Issuer: PROTHENA CORP PUBLIC LTD CO (PRTA)
Original Submission Date:

Reporting Person:

SELKOE DENNIS J.
C/O PROTHENA BIOSCIENCES INC
331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
ORDINARY SHARES, PAR VALUE $0.01 PER SHARE 2021-10-01 M 5,000 a $9.23 7,845 direct
ORDINARY SHARES, PAR VALUE $0.01 PER SHARE 2021-10-01 S 1,757 d $66.35 6,088 direct
ORDINARY SHARES, PAR VALUE $0.01 PER SHARE 2021-10-01 S 1,300 d $67.96 4,788 direct
ORDINARY SHARES, PAR VALUE $0.01 PER SHARE 2021-10-01 S 1,237 d $68.74 3,551 direct
ORDINARY SHARES, PAR VALUE $0.01 PER SHARE 2021-10-01 S 706 d $69.69 2,845 direct
ORDINARY SHARES, PAR VALUE $0.01 PER SHARE 2021-10-01 0 $0.00 1,363 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 9.23 2021-10-01 deemed execution date M 5,000 (d) 2020-05-18 2029-05-22 ordinary shares 5,000 $9.23 11,000 direct
Footnotes
IDfootnote
f1 the transactions reported in the form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person.
f2 the transaction was executed in multiple trades in prices ranging from $66.14 to $67.04, inclusive. the price reported in column 4 above reflects the weighted average sale price. the reporting person hereby undertakes to provide to the securities and exchange commission staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
f3 the transaction was executed in multiple trades in prices ranging from $67.33 to $68.26, inclusive. the price reported in column 4 above reflects the weighted average sale price. the reporting person hereby undertakes to provide to the securities and exchange commission staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
f4 the transaction was executed in multiple trades in prices ranging from $68.44 to $69.30, inclusive. the price reported in column 4 above reflects the weighted average sale price. the reporting person hereby undertakes to provide to the securities and exchange commission staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
f5 the transaction was executed in multiple trades in prices ranging from $69.49 to $70.44, inclusive. the price reported in column 4 above reflects the weighted average sale price. the reporting person hereby undertakes to provide to the securities and exchange commission staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Elevate your investments